C60 did not appear out of nowhere.
Unlike many supplement ingredients that ride a wave of social media buzz and thin research, Carbon 60 has a scientific history that stretches back more than four decades. It involves a Nobel Prize. Hundreds of peer-reviewed studies. One of the most dramatic animal study results ever published. And a molecule so unique that it required scientists to rethink what they knew about carbon itself.
If you are the kind of person who wants to understand the research behind what you put in your body — not just marketing claims, but the actual timeline of scientific discovery — this article is for you.
We have compiled the most important milestones in C60 research, from the moment the molecule was first identified to the current state of the science. Every claim here is grounded in published literature. Where the evidence is strong, we will say so. Where gaps remain, we will be honest about that too.
Let’s start at the beginning. [link to: What Is C60 guide]
1985: The Discovery of a New Form of Carbon
In 1985, three scientists — Harold Kroto of the University of Sussex, and Robert Curl and Richard Smalley of Rice University in Houston — made a discovery that would reshape the field of chemistry.
They were not looking for a supplement ingredient. They were studying something far more fundamental: how carbon atoms behave in the extreme conditions of interstellar space. Using a laser to vaporize graphite and analyzing the resulting carbon clusters, they found something unexpected.
Among the clusters of carbon atoms, one particular configuration kept appearing with remarkable stability. It contained exactly 60 carbon atoms, arranged in a hollow, spherical cage. The structure was made up of 20 hexagons and 12 pentagons — the same geometry as a soccer ball.
The researchers recognized the shape immediately. It was identical to the geodesic dome, the architectural structure pioneered by the American architect and inventor R. Buckminster Fuller. In his honor, they named the molecule buckminsterfullerene. It quickly picked up the informal nickname “buckyball.” Most scientists simply call it C60.
What made this discovery so significant was not just the molecule itself, but what it represented. Before 1985, scientists knew of only two stable forms (or “allotropes”) of pure carbon: diamond and graphite. C60 was a third — a completely new way that carbon atoms could organize themselves. It opened the door to an entire class of previously unknown molecules called fullerenes.
The discovery also hinted at something the researchers could not have fully appreciated at the time: C60’s extraordinary stability and its cage-like structure would eventually prove to have profound biological implications.
1990-1991: Mass Production Becomes Possible
For the first several years after its discovery, C60 remained a laboratory curiosity. Researchers could produce it in tiny amounts — enough to study its properties, but not enough to conduct the kind of extensive research the molecule deserved.
That changed around 1990, when physicists Wolfgang Kratschmer and Donald Huffman developed an arc-vaporization method that made it possible to produce C60 in macroscopic quantities for the first time. This was a pivotal moment. A molecule that had only existed in nanoscale traces could now be manufactured in amounts that enabled serious scientific investigation.
SES Research — the laboratory behind C60 Evo — began manufacturing C60 in 1991. Initially, production was aimed entirely at the research community. Universities, government laboratories, and private research institutions needed reliable, high-purity C60 for their work, and SES Research became one of the earliest and most consistent suppliers.
This is an important point in the timeline, because it marks the transition of C60 from a theoretical curiosity to a material that could actually be studied, tested, and eventually understood at a biological level. Without mass production, the research that followed — including the landmark 2012 study — would never have been possible.
The lab has been producing ESS60 continuously since that year. Over three decades of production experience is part of what allows the ESS60 lab to maintain the purity and consistency standards that ESS60 requires. [link to: What Is C60 guide]
1996: The Nobel Prize in Chemistry
In 1996, the Nobel Committee awarded the Nobel Prize in Chemistry to Harold Kroto, Robert Curl, and Richard Smalley for their discovery of fullerenes.
The Nobel Committee’s citation recognized fullerenes as a fundamentally new class of molecules — a designation that underscores just how significant the discovery was. This was not a minor refinement of existing knowledge. It was a paradigm shift in chemistry, comparable in scope to the discovery of new elements.
The Nobel Prize accomplished something else as well: it put C60 on the global scientific radar in a way that a journal publication alone never could. Researchers across disciplines — chemistry, physics, materials science, and increasingly biology and medicine — took notice. The volume of fullerene research expanded dramatically in the years that followed.
Between 1996 and the early 2000s, the scientific literature on C60 and related fullerenes grew into the hundreds and then thousands of published papers. Researchers explored applications ranging from superconductivity and nanotechnology to drug delivery systems and — critically for our story — biological interactions.
Early 2000s: The Antioxidant Properties Emerge
As researchers began studying C60’s behavior in biological systems, a series of discoveries emerged that would fundamentally change how the molecule was understood.
The Radical Sponge
Multiple research groups discovered that C60 has extraordinary antioxidant properties. Studies found it to be up to 172 times more powerful than Vitamin C as a free radical scavenger.
But more remarkable than its raw potency was its mechanism. Most antioxidants — Vitamin C, Vitamin E, glutathione — work by donating an electron to neutralize a free radical. In doing so, the antioxidant molecule itself is consumed. One antioxidant molecule neutralizes one free radical, and then it is gone.
C60 works differently. Its cage structure allows it to absorb and neutralize multiple free radicals without being destroyed in the process. Researchers began referring to C60 as a “radical sponge” — a molecule that could soak up free radicals repeatedly, providing sustained antioxidant protection rather than a single reaction.
This was unprecedented. No previously known antioxidant worked this way.
Crossing Biological Barriers
Equally significant were the findings about where C60 could go inside the body.
Researchers discovered that C60 could cross cell membranes, entering cells directly rather than remaining in the extracellular space. This meant it could provide antioxidant protection at the intracellular level — where oxidative damage actually occurs.
Studies also showed that C60 could cross the blood-brain barrier, the highly selective membrane that prevents most substances from reaching brain tissue. This property is extremely rare among antioxidants and immediately suggested potential relevance to neurological health and neuroprotection.
Perhaps most importantly, C60 was found to accumulate preferentially in mitochondria — the organelles responsible for cellular energy production. Mitochondria are also the primary source of intracellular free radical generation. A molecule that could concentrate in mitochondria and neutralize free radicals at their point of origin was, biologically speaking, in exactly the right place at the right time.
Taken together, these properties — extreme antioxidant potency, reusable mechanism, cell membrane penetration, blood-brain barrier crossing, mitochondrial accumulation — made C60 unlike any antioxidant previously studied. [link to: C60 Benefits post]
2012: The Landmark Baati Study
If there is a single study that defines C60 research, it is this one.
In 2012, a team of researchers at the University of Paris, led by Tarek Baati and Fathi Moussa, published a paper in the peer-reviewed journal Biomaterials titled “The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene.”
The paper has since been cited hundreds of times in the scientific literature and remains one of the most discussed supplement-relevant studies in the longevity research community.
A Toxicity Study, Not a Longevity Study
This is the detail that makes the Baati study so striking: it was never designed to test lifespan extension. The researchers set out to conduct a chronic toxicity assessment. Their goal was to determine how much C60 dissolved in olive oil rats could tolerate before it caused harm. They wanted to establish a toxicity threshold.
They never found one.
The Experimental Design
The researchers divided Wistar rats into three groups:
- Water control group — received water only
- Olive oil group — received olive oil without C60
- C60 in olive oil group — received C60 dissolved in olive oil
The C60 solution was administered repeatedly over several months. After dosing ended, the researchers simply observed the animals for the rest of their natural lives.
The Results
The results stunned the research community.
- The water control group lived normal lifespans for Wistar rats, as expected.
- The olive oil group lived approximately 18% longer than the water group — consistent with the known health benefits of olive oil.
- The C60 in olive oil group lived up to 90% longer than the water control group.
To put that number in context: in the entire history of peer-reviewed mammalian longevity research, no other single intervention has produced a result of this magnitude.
The study also found:
- Zero signs of toxicity at any dose tested. The researchers explicitly described C60 as having “no acute or subacute toxicity.”
- The C60 group showed dramatic protection against carbon tetrachloride, a potent liver toxin. Exposure that would normally cause severe liver damage had markedly reduced effects in the C60-treated rats.
- The researchers were so surprised by their own data that they repeated the experiment. The results held.
The C60 Evo Connection
The C60 used in this study was supplied by SES Research — the same laboratory that produces C60 Evo’s ESS60 today. This is not incidental. The purity and preparation of the C60 used in the study are directly relevant to the results, and ESS60 maintains the same standards that were used in the research.
The Critical Caveat
We state this in every discussion of this study, and we will state it here again: the Baati study was conducted in rats, not humans. Rats and humans share many of the same biological pathways — particularly those related to oxidative stress, mitochondrial function, and inflammation — but a result in rats does not automatically translate to an identical result in humans.
The study is remarkable. The biological plausibility is strong. But intellectual honesty requires acknowledging that direct human evidence of this magnitude does not yet exist. [link to: C60 Anti-Aging post]
2012-2020: Expanding the Research Base
The Baati study catalyzed a new wave of C60 research. Over the following years, studies explored C60’s effects across multiple biological systems. While none produced a single result as dramatic as the lifespan study, the cumulative body of evidence built a detailed picture of C60’s biological activity.
Neuroprotection
Multiple studies examined C60’s effects on neural tissue. Research demonstrated that C60 could protect neurons from oxidative damage in various experimental models. Given C60’s ability to cross the blood-brain barrier and its potent antioxidant activity, these findings were consistent with the molecule’s known properties and suggested relevance to supporting healthy cognitive function. [link to: C60 Brain Health post]
Anti-Inflammatory Activity
Researchers found that C60 reduced inflammatory markers across multiple tissue types. Since chronic inflammation and oxidative stress are closely linked biological processes — each driving the other in a destructive cycle — C60’s dual role as both antioxidant and anti-inflammatory agent was significant. [link to: C60 Joint Health post]
Skin Protection
Studies showed that C60 could protect against UV-induced oxidative damage in skin cells. Given that UV exposure is one of the primary drivers of skin aging through free radical generation, this research supported C60’s potential role in supporting skin health from the inside out. [link to: C60 Skin Benefits post]
Joint and Cartilage Health
C60’s anti-inflammatory properties were found to be relevant to joint tissue, with research demonstrating reduced inflammatory markers in cartilage and joint-related models. For people dealing with everyday joint stiffness and discomfort, these findings were particularly relevant.
Liver Protection
Multiple studies confirmed C60’s hepatoprotective properties — its ability to protect liver tissue from toxic insult. This was consistent with the Baati study’s findings regarding carbon tetrachloride protection and added to the evidence that C60 supports the body’s natural detoxification processes.
Early-Stage Cancer Research
Some researchers investigated C60’s interactions with tumor cells in preliminary studies. We want to be very clear about this area of research: it is extremely early-stage. These are primarily in vitro (cell culture) and early animal studies. No claims should be made — and we make none — about C60 as a cancer treatment, prevention, or cure. We mention this research only for completeness in the timeline, to acknowledge that it exists in the scientific literature.
Dermatological Applications
C60 was also studied for topical applications, with researchers examining its potential for direct skin application in various formulations. This line of research explored C60’s antioxidant properties in a dermatological context.
2020-Present: The Consumer Supplement Era
The period from 2020 onward marks a significant transition in C60’s story: the shift from a molecule studied almost exclusively in laboratories to one available to consumers as a daily supplement.
ESS60 — Elemental Safe Spheres 60 — is the form of C60 specifically developed for human consumption. Unlike industrial-grade C60 produced for electronics, lubricants, or general research purposes, ESS60 is manufactured to standards appropriate for dietary supplementation. It is the form we use in every C60 Evo product, and it is the same form that was used in the Baati study. [link to: ESS60 vs C60 post]
Several developments define this current era:
A growing user community. Thousands of people now take ESS60 daily. While individual experiences vary, commonly reported effects include improved energy, better joint comfort, improved skin appearance, and a general sense of vitality. These reports are anecdotal — they are not clinical data — but their consistency across a broad user base is notable.
Increasing interest from longevity and biohacking communities. C60 has gained significant attention among people who actively research and optimize their health. This community tends to be science-literate, skeptical of unsupported claims, and drawn to C60 precisely because of the depth of its research base.
Emerging human research. Human clinical studies on C60 are beginning to appear, though the body of human data remains limited compared to the extensive animal research. This is the key frontier — bridging the gap between the compelling animal evidence and rigorous human clinical data.
Continued laboratory research. C60 studies continue to be published across multiple fields. The molecule’s unique properties ensure ongoing scientific interest.
What the Research Tells Us — and What It Does Not
If you have read this far, you deserve a clear, honest summary of where the science stands. No spin. No marketing language. Just an accurate picture.
What We Know
The following statements are supported by published, peer-reviewed research:
- C60 is a uniquely powerful antioxidant, with potency measured at up to 172 times that of Vitamin C
- C60 functions as a radical sponge, neutralizing multiple free radicals without being consumed — a mechanism no other known antioxidant shares
- C60 crosses cell membranes and can provide intracellular antioxidant protection
- C60 crosses the blood-brain barrier, a property that is rare among antioxidant compounds
- C60 accumulates in mitochondria, the organelles at the center of both energy production and free radical generation
- C60 has potent anti-inflammatory properties demonstrated across multiple tissue types
- C60 in olive oil produced up to 90% lifespan extension in rats in a controlled, peer-reviewed study
- C60 has shown no toxicity in over 30 years of research and use, including in a study specifically designed to find a toxic dose
What We Do Not Know Yet
The following represent gaps in the current evidence:
- Long-term human clinical trial data. While the animal evidence is extensive and compelling, large-scale human clinical trials with long follow-up periods have not yet been completed.
- Optimal human dosing based on clinical studies. Current dosing recommendations are based on the animal research, user experience, and general safety data — not on dose-finding clinical trials in humans.
- Specific health outcome data in humans. We cannot state with clinical certainty what specific health outcomes C60 produces in humans at specific doses over specific timeframes.
Putting This in Context
Here is what matters: the mechanism is well understood, the animal data is compelling, and the human data is catching up.
This is not a reason to dismiss C60. It is a reason to take it seriously while maintaining realistic expectations.
It is also worth noting that most popular supplements on the market today have far less research behind them than C60 does. Many best-selling supplements are based on a handful of small studies, limited animal data, or traditional use alone. C60 has a Nobel Prize, thousands of published papers, a 30+ year manufacturing history, and one of the most dramatic animal study results in the history of supplement research.
The standard for C60 should be high. We agree with that. But the standard should be applied consistently — and by that measure, C60’s evidence base is among the strongest in the supplement world. [link to: Is C60 Safe post]
Frequently Asked Questions
Is C60 research legitimate?
Yes. C60 research is published in peer-reviewed scientific journals, conducted at accredited universities and research institutions worldwide, and the discovery of C60 itself was awarded the Nobel Prize in Chemistry in 1996. The landmark 2012 lifespan study was published in Biomaterials, a respected, peer-reviewed journal. C60 is one of the most thoroughly studied molecules in modern chemistry.
How many studies have been done on C60?
Thousands. The broader fullerene literature encompasses thousands of published papers across chemistry, physics, materials science, and biology. The subset focused specifically on C60’s biological and health-related properties includes hundreds of published studies. Research continues to be published regularly.
Has C60 been tested on humans?
Human research on C60 is in its early stages. The most robust data comes from animal studies, particularly the 2012 Baati study in rats. Human clinical studies are beginning to emerge, but the body of human data is still limited compared to the extensive animal literature. This is an active area of research. In the meantime, ESS60 has been manufactured and used since 1991 with no serious adverse effects reported in the published literature.
Who funded the 2012 Baati study?
The 2012 study was conducted by academic researchers at the University of Paris. It was not funded by a supplement company or conducted for commercial purposes. The researchers were investigating C60’s toxicity profile — a basic science question. The lifespan extension results were an unexpected finding that surprised the researchers themselves. The C60 used in the study was manufactured by SES Research, the laboratory behind C60 Evo.
Is C60 research ongoing?
Yes. New studies on C60 and fullerenes continue to be published regularly in peer-reviewed journals. Active research areas include neuroprotection, anti-inflammatory mechanisms, skin health, mitochondrial function, and the development of human clinical data. Interest in C60’s biological properties continues to grow within the scientific community.
Where can I read the original studies?
The 2012 Baati study is publicly accessible: Baati, T., Bourasset, F., Gharbi, N., et al. “The prolongation of the lifespan of rats by repeated oral administration of [60]fullerene.” Biomaterials, 33(19), 4936-4946, 2012. It is available through PubMed and most academic databases. The broader C60 literature can be searched through Google Scholar, PubMed, or any university library system using search terms like “C60,” “fullerene,” or “buckminsterfullerene.”
Conclusion: Four Decades of Science, and Counting
C60’s scientific journey is unlike that of any other supplement ingredient.
It began as a laboratory curiosity in 1985 — an unexpected discovery by researchers who were studying carbon atoms in space, not looking for a health product. It earned the Nobel Prize in Chemistry in 1996, recognizing fullerenes as an entirely new class of molecules. It yielded one of the most dramatic animal study results in supplement research history in 2012, when a study designed to find toxicity instead found a 90% lifespan extension with zero adverse effects.
Along the way, researchers have built a detailed understanding of how C60 works: a radical sponge antioxidant of extraordinary potency that crosses cell membranes, penetrates the blood-brain barrier, and concentrates in mitochondria — exactly where oxidative damage originates.
The human clinical evidence is still catching up to the animal data. We are transparent about that. But the biological mechanisms are well understood, the safety profile is strong, and the body of research is deep. For people who make decisions based on evidence rather than hype, C60’s research base speaks for itself.
The lab behind C60 Evo has been part of this story since 1991. SES Research has manufactured C60 for over three decades. The lab supplied the C60 used in the landmark 2012 study. And it produces ESS60, the only form of C60 specifically developed for human consumption.
If you are ready to experience what 40 years of research has produced, we invite you to explore our products.
[Shop C60 Evo ESS60 Products] [link to: Shop page]
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The information provided is for educational purposes only and is not intended as medical advice. Consult your healthcare provider before starting any new supplement regimen.
Keep Reading
- Is C60 Safe? 30 Years of Research — Read our safety guide on C60 supplements
- What Is C60? Complete Guide — Start with the basics in our complete C60 guide
- C60 Benefits: What the Science Says — Explore the health benefits that C60 research supports
Internal Link Suggestions:
– [link to: What Is C60 guide] — link from introduction and 1985 discovery section
– [link to: C60 Anti-Aging post] — link from 2012 Baati study discussion
– [link to: Is C60 Safe post] — link from “What the Research Tells Us” section
– [link to: C60 Benefits post] — link from antioxidant properties section
– [link to: C60 Brain Health post] — link from neuroprotection research section
– [link to: C60 Joint Health post] — link from anti-inflammatory research section
– [link to: C60 Skin Benefits post] — link from skin protection research section
– [link to: ESS60 vs C60 post] — link from consumer supplement era section
– [link to: Shop page] — link from conclusion CTA
Schema Markup Note: Implement FAQ schema (FAQPage) for the six questions in the FAQ section above. Each question-answer pair should be marked up as a separate Question entity within the FAQ schema to enable rich results in Google Search.